Gaush Meditech Ltd
Gaush Meditech Ltd., headquartered in China, is a prominent player in the medical technology industry, specialising in innovative healthcare solutions. Founded in [year], the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of advanced medical devices and diagnostic equipment. With a commitment to quality and innovation, Gaush Meditech offers a diverse range of core products, including [specific products or services], which are distinguished by their cutting-edge technology and user-friendly design. The company has achieved notable milestones, positioning itself as a trusted name in the healthcare sector, recognised for its contributions to improving patient outcomes and enhancing medical practices. Gaush Meditech Ltd. continues to lead the way in medical advancements, striving to meet the evolving needs of healthcare professionals worldwide.
DitchCarbon Score
How does Gaush Meditech Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gaush Meditech Ltd's score of 17 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gaush Meditech Ltd's reported carbon emissions
In 2022, Gaush Meditech Ltd reported total carbon emissions of approximately 1,750,310 kg CO2e. This figure includes 136,600 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 1,613,710 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Currently, there are no disclosed reduction targets or climate pledges from Gaush Meditech Ltd, indicating a potential area for future commitment in addressing climate change. The absence of Scope 3 emissions data suggests that the company may not yet be fully accounting for its entire carbon footprint, which typically includes emissions from the supply chain and product use. As the company continues to operate within the global market, enhancing its climate commitments and establishing measurable reduction targets could significantly contribute to its sustainability efforts and align with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 136,600 |
| Scope 2 | 1,613,710 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gaush Meditech Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
